Jeena Sikho Lifecare Stock Screener | Share Price & Fundamental Analysis
JSLL
Pharmaceuticals
Share Price NSE
₹539.70
▼
-13.95 (-2.52%)
Share Price BSE
₹539.90
▼
-11.65 (-2.11%)
Track Jeena Sikho Lifecare share price live with TickJournal's free stock screener.
Analyze Jeena Sikho Lifecare share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Jeena Sikho Lifecare Market Cap
₹6,881.91 Cr.
JSLL P/E Ratio (TTM)
36.71
Jeena Sikho Lifecare P/B Ratio
20.97
EPS (TTM)
₹24.84
Dividend Yield
0.18%
Debt to Equity
0.05
JSLL 52 Week High
₹837.55
Jeena Sikho Lifecare 52 Week Low
₹400.50
Operating Margin
33.00%
Profit Margin
17.86%
JSLL Revenue (TTM)
₹140.00
EBITDA
₹46.00
Net Income
₹25.00
Total Assets
₹151.00
Total Equity
₹126.00
Jeena Sikho Lifecare Share Price History - Stock Screener Chart
Screen JSLL historical share price movements with interactive charts. Analyze price trends and patterns.
Jeena Sikho Lifecare Company Profile - Fundamental Screener
Screen Jeena Sikho Lifecare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for JSLL shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0J5801029
Jeena Sikho Lifecare Balance Sheet Screener
Screen JSLL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2023 | 2022 |
|---|---|---|
| Assets | ||
| Total Assets | 151 | 62 |
| Current Assets | 78 | 22 |
| Fixed Assets | 60 | 29 |
| Liabilities | ||
| Total Liabilities | 0 | 0 |
| Current Liabilities | 1 | 1 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 126 | 37 |
| Share Capital | 14 | 10 |
| Reserves & Surplus | 112 | 26 |
Jeena Sikho Lifecare Income Statement Screener - Profit & Revenue Analysis
Screen Jeena Sikho Lifecare income statement and profit fundamentals.
Analyze JSLL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Jeena Sikho Lifecare share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|
| Revenue | 140 | 175 | 191 | 224 | 103 | 118 | 116 |
| Expenses | 94 | 96 | 98 | 121 | 75 | 74 | 86 |
| EBITDA | 46 | 80 | 94 | 103 | 28 | 44 | 30 |
| Operating Profit % | 33.00% | 45.00% | 48.00% | 45.00% | 25.00% | 35.00% | 26.00% |
| Depreciation | 9 | 10 | 10 | 11 | 5 | 6 | 9 |
| Interest | 3 | 2 | 4 | 3 | 2 | 2 | 4 |
| Profit Before Tax | 34 | 69 | 79 | 89 | 21 | 35 | 18 |
| Tax | 9 | 17 | 20 | 22 | 5 | 9 | 5 |
| Net Profit | 25 | 51 | 59 | 67 | 16 | 27 | 13 |
| EPS | 2.04 | 4.12 | 4.73 | 5.36 | 1.27 | 2.14 | 1.06 |
Jeena Sikho Lifecare Cash Flow Screener - Liquidity Fundamentals
Screen JSLL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2023-March | 2022-March |
|---|---|---|
| Operating Activities | 15 | 16 |
| Investing Activities | -33 | -19 |
| Financing Activities | 48 | -5 |
| Net Cash Flow | 29 | -7 |
Jeena Sikho Lifecare Shareholding Pattern Screener
See Jeena Sikho Lifecare shareholding pattern with promoter, FII, and DII holdings.
Check Jeena Sikho Lifecare promoter holding and ownership changes for JSLL on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Aug | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Sept | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 63.53% | 63.53% | 63.53% | 63.61% | 63.62% | 67.91% | 65.84% | 66.20% |
| FII Holding | 0.00% | 0.00% | 5.99% | 6.59% | 6.31% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.18% | 0.15% | 0.11% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 16.67% | 17.05% | 17.20% | 17.32% | 18.19% | 17.34% | 16.72% | 15.28% |
| Other Holding | 19.80% | 19.41% | 13.10% | 12.33% | 11.76% | 14.75% | 17.44% | 18.52% |
| Shareholder Count | 5,967 | 6,603 | 7,434 | 16,362 | 22,181 | 2,721 | 3,423 | 663 |
Jeena Sikho Lifecare Share Dividend Screener - Share Yield Analysis
Check Jeena Sikho Lifecare dividend history with payout and yield data.
View Jeena Sikho Lifecare dividend details including ex-dates and amounts for JSLL stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹5.47 | 0.99% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Jeena Sikho Lifecare Stock Index Membership
See which indices include Jeena Sikho Lifecare stock.
Check JSLL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Jeena Sikho Lifecare Market Events Screener - Corporate Actions
Get Jeena Sikho Lifecare corporate actions including splits, bonuses, and buybacks.
Check Jeena Sikho Lifecare stock events that may affect JSLL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 14.22% | ||
| Dividend | ₹ 1.10 /share | -65.33% | ||
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | 9.43% |
| 2025-11-06 | 2025-11-06 | Quarterly Result Announcement | NA | 5.47% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | 2.44% |
| 2025-06-12 | 2025-04-21 | Split | 2:10 | 0.00% |
| 2025-05-16 | 2025-05-16 | Quarterly Result Announcement | NA | 3.04% |
| 2024-11-11 | 2024-11-11 | Quarterly Result Announcement | NA | -0.97% |
| 2024-08-28 | 2024-08-28 | Annual General Meeting | NA | 17.80% |
| 2024-08-20 | 2024-08-20 | Dividend | ₹ 4.18 /share | 26.31% |
| 2024-02-27 | 2024-02-27 | Extraordinary General Meeting | NA | 33.82% |
| 2023-11-02 | 2023-11-02 | Bonus | 4:5 | 17.38% |
| 2023-08-25 | 2023-08-25 | Dividend | ₹ 2.00 /share | 219.83% |
Jeena Sikho Lifecare Competitors Screener - Peer Comparison
Screen JSLL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 430,345 | 39.32 | 54,729 | 9.71% | 10,980 | 56.35 |
| Divis Laboratories | 159,215 | 64.39 | 9,712 | 18.67% | 2,191 | 39.57 |
| Torrent Pharmaceuticals | 144,367 | 64.00 | 11,539 | 6.99% | 1,911 | 49.85 |
| Dr Reddys Laboratories | 106,975 | 19.68 | 33,741 | 16.73% | 5,725 | 49.71 |
| Lupin | 106,653 | 22.98 | 22,910 | 13.74% | 3,306 | 56.95 |
| Cipla | 100,349 | 22.17 | 28,410 | 7.12% | 5,291 | 34.82 |
| Zydus Life Science | 90,229 | 18.09 | 23,511 | 18.55% | 4,615 | 49.23 |
| Mankind Pharma | 84,163 | 46.25 | 12,744 | 20.90% | 2,007 | 44.70 |
| Aurobindo Pharma | 76,329 | 21.80 | 32,346 | 9.43% | 3,484 | 63.55 |
| Alkem Laboratories | 63,902 | 26.83 | 13,458 | 3.70% | 2,216 | 45.83 |
Jeena Sikho Lifecare Company Announcements - News Screener
Screen JSLL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-27 | Closure of Trading Window | - |
| 2026-03-27 | Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Study And Case Reports. | - |
| 2026-03-17 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-03-09 | Amendment To The Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information. | - |
| 2026-03-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-23 | Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Studies And Case Report. | - |
| 2026-02-19 | Jeena Sikho Lifecare Limited Has Informed The Exchange About Receipt Of NABH Certificate Of Accreditation For Dehradun Hospital. | - |
| 2026-02-16 | Jeena Sikho Lifecare Limited Has Informed The Exchange About Proposal For Establishment Of New Hospital In Ahmedabad. | - |
| 2026-02-13 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-08 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-07 | Jeena Sikho Lifecare Limited Has Submitted To The Exchange The Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report Thereon For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-02-07 | Board Meeting Outcome for Jeena Sikho Lifecare Limited Has Submitted To The Exchange The Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report Thereon For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-02-04 | Jeena Sikho Lifecare Limited Has Informed The Exchange About Commencement Of Operation Of Hospitals In Siliguri West Bengal And Bhagalpur Bihar. | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-04 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-03 | Board Meeting Intimation for To Inter Alia Consider And Approve The Unaudited Financial Results (Standalone And Consolidated) Of The Company For The Quarter Ended 31St December 2025 Along With The Limited Review Report Thereon. | - |
| 2026-01-22 | Jeena Sikho Lifecare Limited Has Informed The Exchange About Publication Of Case Report | - |
| 2026-01-21 | Board Meeting Outcome for Jeena Sikho Lifecare Limited Has Informed The Exchange Regarding Outcome Of Board Meeting Held On January 21 2026-Approval Of Loan Agreement With Jeena Sikho International LLC A Wholly Owned Subsidiary ( WOS ) Of The Company. | - |